VisionWave Holdings has agreed to acquire a controlling 52% stake in Foresight Autonomous Holdings for $17.5 million in stock, aiming to integrate Foresight's advanced camera-based sensing with its own RF-based AI detection technology. This merger will create a unified multi-modal perception platform combining RF sensing, optical/thermal vision, and AI video analytics, enhancing defense and security capabilities. The deal includes staged share exchanges and board representation for VisionWave, pending regulatory and shareholder approvals. This strategic move positions VisionWave to lead in advanced sensing technologies for defense, security, and autonomous systems.
Lemonade, a tech-driven insurance company, has expanded its renters insurance to North Dakota, offering fast, affordable coverage starting at $5 per month. The service allows renters to manage policies and claims via an app, with about 40% of claims ...
DBV Technologies announced a change in its participation at the 47th Annual Global Healthcare Conference by Goldman Sachs, held on June 9, 2026, in Miami. The company's CEO, Daniel Tassé, will not attend the informal discussion as initially planned d...
Antag Therapeutics has elected Keith Leonard as Chairman of its Board of Directors to support the development of its obesity treatment drug, AT7687. Leonard brings 30 years of biopharmaceutical leadership experience, including roles as CEO and Chairm...
Revenium introduced AI Insights, a tool that analyzes enterprise AI usage to pinpoint and rank budget waste, linking each issue to specific transactions for easy fixes. This helps companies recover costs by identifying inefficiencies like outdated mo...
MitoRx Therapeutics has strengthened its leadership team by appointing Alison Strutt as CFO, László Tankó as Consultant CMO, and Sam Fazeli as Non-Executive Director. These hires come as MitoRx prepares to advance its lead drug candidate, MTRX31, a n...
